13 July 2017 - Pope Woodhead, UK
Over the last few years there has been a significant investment in to a pipeline of cell and gene therapy products across oncology as well as in rare diseases and diseases with high unmet needs. While the pipeline of products offer the promise of transforming treatment and outcomes for patients, there are certain environmental and product related barriers to access and/or utilisation.
In this webinar we covered:
- Investigations on the environmental and product related opportunities and challenges for market access and uptake
- Identify how companies can prepare strategies for successful reimbursement and uptake of a novel therapy
Speakers: Akshay Kumar at Pope Woodhead
Click here to download the webinar Q & A